Trials / Recruiting
RecruitingNCT06807866
Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT
Use of Duloxetine for Perioperative Pain Control After Total Hip Arthroplasty: Randomized Controlled Clinical Trial (RCT)
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Participants will come in person and receive a one time 60 mg dose by mouth. |
| OTHER | Placebo | Participants will come in person and receive a one time 60 mg placebo pill dose by mouth. |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2025-02-04
- Last updated
- 2026-03-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06807866. Inclusion in this directory is not an endorsement.